Boyu Capital — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Brii Biosciencesbriibio.com inMay 2018

Hong Kong-listed (2137.HK) biotech founded in 2018 developing infectious disease therapies, led by hepatitis B functional-cure programs.

Zhi Hong(Founder)in

Co-investorsARCH Venture Partners 6 Dimensions Capital Blue Pool Capital Sequoia Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Viela Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.